ArticleArchives of virology2026
Emergence of norovirus GII.7 and predominance of recombinant strains in pediatric acute gastroenteritis in Japan, 2021-2024.
Article in Archives of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
18 authors.
Funding
Abstract
Noroviruses (NoVs) are a leading cause of acute gastroenteritis (AGE) worldwide, with genetic diversity driven by recombination and genotype replacement. This study investigated the prevalence and molecular characteristics of NoVs among Japanese children with AGE from July 2021 to June 2024. A total of 1,095 stool samples were collected from three prefectures (Kyoto, Osaka, and Shizuoka), and NoV RNA was detected in 456 cases (41.6%). Genogroup GII predominated (96.9%), while GI infections were rare. Genotyping identified eight genotypes, including two GI (GI.1, GI.6) and six GII (GII.2, GII.3, GII.4, GII.6, GII.7, GII.17). GII.4 remained the predominant genotype (71.7%) throughout the study period. Notably, GII.7 emerged in 2023-2024 and became the second most prevalent genotype. Analysis of the ORF1/ORF2 junction identified multiple RdRp-capsid combinations, with recombinant strains accounting for 92.5% of detections. The predominant recombinant lineages were GII.4[P16] and GII.4[P31], followed by GII.2[P16]. Phylogenetic analysis indicated close relatedness to strains circulating internationally. These findings demonstrate the sustained predominance of GII.4, the emergence of GII.7, and the high prevalence of recombinant strains among Japanese children, highlighting the importance of continuous molecular surveillance.
Indexed as
Identifiers
42262572What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.